PTC THERAPEUTICS INC (PTCT) Stock Analyst Earnings Estimates
NASDAQ:PTCT - Nasdaq - US69366J2006 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 538.6M 41.44% | 698.8M 29.74% | 937.822M 34.20% | 819.8M -12.58% | 932.12M 13.70% | 899.62M -3.49% | 1.028B 14.27% | 1.249B 21.50% | 1.509B 20.82% | 1.693B 12.19% | 1.597B -5.67% | 1.559B -2.38% | |
| EBITDA YoY % growth | -310.27M 17.85% | -285.16M 8.09% | 14.888M 105.22% | -46.459M -412.06% | -50.138M -7.92% | 73.104M 245.81% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -374.4M 11.11% | -414M -10.58% | -221.702M 46.45% | -169.398M 23.59% | 159.67M 194.26% | -14.707M -109.21% | 166.44M 1,231.69% | 318.97M 91.64% | 486.21M 52.43% | 639.38M 31.50% | 565.27M -11.59% | 320.69M -43.27% | |
| Operating Margin | -69.51% | -59.24% | -23.64% | -20.66% | 17.13% | -1.63% | 16.19% | 25.54% | 32.22% | 37.77% | 35.40% | 20.57% | |
| EPS YoY % growth | -7.43 -13.61% | -7.33 1.35% | -6.54 10.78% | -4.78 26.94% | -0.70 85.40% | -1.80 -158.50% | 1.95 208.06% | 4.01 105.76% | 3.68 -8.14% | 4.97 34.90% | 4.00 -19.51% | 3.94 -1.53% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.75 -211.92% | 0.16 113.39% | -1.11 12.37% | -0.80 42.72% | -0.68 8.61% | -0.35 -315.87% | -0.12 89.00% | 0.07 108.97% | 0.17 125.35% | 0.61 276.47% | 0.69 666.67% | 0.67 842.86% |
| Revenue Q2Q % growth | 230.33M -24.99% | 151.78M -27.76% | 166.08M -11.05% | 204.23M 3.78% | 223.28M -3.06% | 251.15M 65.47% | 287.27M 72.97% | 321.92M 57.63% | 335.88M 50.43% | 392.54M 56.30% | 423.51M 47.43% | 441.32M 37.09% |
| EBITDA Q2Q % growth | 48.287M -80.08% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -48.96K -100.84% | 283.65M 724.05% | -53.461M -39.01% | -15.391M 70.78% | -4.834M -9,772.92% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -1.39 21.02% | -1.47 | 0.08 | 5.49% |
| Q2 2024 Q2Q % growth | -1.27 52.26% | -1.07 | -0.20 | -18.68% |
| Q1 2024 Q2Q % growth | -1.20 36.17% | -1.27 | 0.07 | 5.18% |
| Q4 2023 Q2Q % growth | -0.24 87.30% | 0.51 | -0.75 | -147.48% |
| Q3 2023 Q2Q % growth | -1.76 -15.03% | -1.19 | -0.57 | -47.41% |
| Q2 2023 Q2Q % growth | -2.66 -24.88% | -1.27 | -1.39 | -109.52% |
| Q1 2023 Q2Q % growth | -1.88 -5.62% | -1.32 | -0.56 | -41.94% |
| Q4 2022 Q2Q % growth | -1.89 6.90% | -1.62 | -0.27 | -16.38% |
| Q3 2022 Q2Q % growth | -1.53 19.05% | -1.27 | -0.26 | -20.74% |
| Q2 2022 Q2Q % growth | -2.13 -26.79% | -1.36 | -0.77 | -56.73% |
| Q1 2022 Q2Q % growth | -1.78 2.73% | -1.54 | -0.24 | -15.81% |
| Q4 2021 Q2Q % growth | -2.03 -87.96% | -1.68 | -0.35 | -20.96% |
| Q3 2021 Q2Q % growth | -1.89 -83.50% | -1.52 | -0.37 | -24.74% |
| Q2 2021 Q2Q % growth | -1.68 35.88% | -1.85 | 0.17 | 9.39% |
| Q1 2021 Q2Q % growth | -1.83 -1.10% | -1.54 | -0.29 | -18.59% |
| Q4 2020 Q2Q % growth | -1.08 21.17% | -0.95 | -0.13 | -13.15% |
| Q3 2020 Q2Q % growth | -1.03 2.83% | -0.06 | -0.97 | -1,674.08% |
| Q2 2020 Q2Q % growth | -2.62 -249.33% | -1.33 | -1.29 | -97.71% |
| Q1 2020 Q2Q % growth | -1.81 -40.31% | -1.35 | -0.46 | -33.60% |
| Q4 2019 Q2Q % growth | -1.37 | -0.52 | -0.85 | -165.09% |
| Q3 2019 Q2Q % growth | -1.06 | -0.77 | -0.29 | -37.42% |
| Q2 2019 Q2Q % growth | -0.75 | -0.60 | -0.15 | -25.71% |
| Q1 2019 Q2Q % growth | -1.29 | -0.78 | -0.51 | -66.22% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 196.786M 0.11% | 176.11M | 20.676M | 11.74% |
| Q2 2024 Q2Q % growth | 186.704M -12.68% | 189.03M | -2.326M | -1.23% |
| Q1 2024 Q2Q % growth | 210.118M -4.66% | 173.1M | 37.018M | 21.39% |
| Q4 2023 Q2Q % growth | 307.056M 83.43% | 327.72M | -20.664M | -6.31% |
| Q3 2023 Q2Q % growth | 196.576M -9.45% | 214.4M | -17.824M | -8.31% |
| Q2 2023 Q2Q % growth | 213.808M 29.19% | 211.13M | 2.678M | 1.27% |
| Q1 2023 Q2Q % growth | 220.382M 48.21% | 204.49M | 15.892M | 7.77% |
| Q4 2022 Q2Q % growth | 167.4M 1.33% | 192.92M | -25.52M | -13.23% |
| Q3 2022 Q2Q % growth | 217.1M 56.52% | 190.64M | 26.46M | 13.88% |
| Q2 2022 Q2Q % growth | 165.5M 41.82% | 165.33M | 170K | 0.10% |
| Q1 2022 Q2Q % growth | 148.7M 26.12% | 150M | -1.3M | -0.87% |
| Q4 2021 Q2Q % growth | 165.2M 38.94% | 153.85M | 11.35M | 7.38% |
| Q3 2021 Q2Q % growth | 138.7M 17.15% | 122.85M | 15.85M | 12.90% |
| Q2 2021 Q2Q % growth | 116.7M 55.19% | 112.71M | 3.99M | 3.54% |
| Q1 2021 Q2Q % growth | 117.9M 72.62% | 100.78M | 17.12M | 16.99% |
| Q4 2020 Q2Q % growth | 118.9M 23.21% | 113.58M | 5.32M | 4.68% |
| Q3 2020 Q2Q % growth | 118.4M 65.83% | 114.45M | 3.95M | 3.45% |
| Q2 2020 Q2Q % growth | 75.2M -12.05% | 84.434M | -9.234M | -10.94% |
| Q1 2020 Q2Q % growth | 68.3M 27.43% | 81.664M | -13.364M | -16.36% |
| Q4 2019 Q2Q % growth | 96.5M | 97.15M | -650K | -0.67% |
| Q3 2019 Q2Q % growth | 71.4M | 74.482M | -3.082M | -4.14% |
| Q2 2019 Q2Q % growth | 85.5M | 80.211M | 5.289M | 6.59% |
| Q1 2019 Q2Q % growth | 53.6M | 71.407M | -17.807M | -24.94% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 29% | 58.49% | 1.38% | 7.58% |
| Revenue | 17.68% | 58.59% | 1.19% | 9.06% |